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Highlights 
 Redox titrations were performed on the isolated detergent-solubilized bovine enzyme 
 The Soret- and α-band was analyzed with precise multiwavelength spectroscopy 
 The presence of the 602nm form of heme a was verified 
 This state was stabilized at high pH and on binding of azide 
 Results confirm that redox titrations can be successfully performed in living cells 
 
Keywords  Cytochrome oxidase, midpoint potential, proton pumping, heme spectroscopy, redox 
titration, azide. 
Abstract 
Cytochrome oxidase is the terminal oxidase of the mitochondrial electron transport chain and 
pumps 4 protons per oxygen reduced to water. Spectral shifts in the α-band of heme a have been 
observed in multiple studies and these shifts have the potential to shed light on the proton pumping 
intermediates. Previously we found that heme a had two spectral components in the α-band during 
redox titrations in living RAW 264.7 mouse macrophage cells, the classical 605nm form and a blue-
shifted 602nm form. To confirm these spectral changes were not an artifact due to the complex 
milieu of the living cell, redox titrations were performed in the isolated detergent-solubilized bovine 
enzyme from both the Soret- and α-band using precise multiwavelength spectroscopy. This data 
verified the presence of the 602nm form in the α-band, revealed a similar shift of heme a in the 
Soret-band and ruled out the reversal of calcium binding as the origin of the blue shift. The 602nm 
form was found to be stabilized at high pH or by binding of azide, which is known to blue shift the 
α-band of heme a. Azide also stabilized the 602nm form in the living cells. It is concluded there is a 
form of cytochrome oxidase in which heme a undergoes a blue shift to a 602nm form and that redox 
titrations can be successfully performed in living cells where the oxidase operates in its authentic 
environment and in the presence of a proton motive force. 
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1. Introduction 
Cytochrome oxidase is the terminal oxidase of the mitochondrial electron transport chain which 
pumps 4 protons per oxygen reduced [1]. Electrons from intermembrane cytochrome c (Cytc) are 
first passed to the CuA centre located on the cytosolic side of the enzyme and subsequently to heme 
a, located at a depth of approximately 1/3 of the membrane thickness [2-3]. Electrons are then 
passed parallel to the membrane to the binuclear centre (BNC) consisting of heme a3 and CuB, 
where oxygen is reduced to water. The catalytic cycle has been well documented [4]. Oxygen binds 
to the binuclear centre when both heme a3 and CuB are reduced (R-state) to form the A-state, and is 
reduced in a concerted 4-electron transfer [5] to form the P-state with a ΔG that makes this reaction 
essentially irreversible [6]. Two electrons are derived from heme a3, one from CuB and one from a 
nearby tyrosine. The BNC and the tyrosine are then re-reduced by 4 sequential electron transfers 
from heme a forming the F, O, E and R state but, in the low dielectric constant of the protein, each 
electron must be accompanied by a substrate proton for charge neutralization [7]. These substrate 
protons combine with the charged oxygen intermediates ligated to the BNC to form water. 
Proton pumping is initiated by reduction of heme a which raises the pKa of a pump loading site 
(PLS) above the hemes allowing it to be protonated from the N-side [8]. Prior to protonation, the 
midpoint potential (Em) of heme a3 and CuB is far below heme a so that the equilibrium prevents the 
BNC from becoming reduced. Protonation of the PLS raises the midpoint potential of the BNC 
which changes the equilibrium allowing substantial electron transfer to the BNC. Subsequent 
uptake of the substrate proton neutralizes the charge at the binuclear centre, lowers the pKa of the 
PLS and ejects the pump proton to the P-side. The precise details of the pumping mechanism are 
still poorly understood. Much of the information on the catalytic cycle and proton pumping has 
been gained using dual-wavelength difference spectroscopy of the hemes. However this analysis 
neglects the small spectral shifts in the α-band that have been observed in redox titrations [9-11], 
after CO photolysis in the mixed valence enzyme [12], after photo injection of an electron in the 
CuA site [8] and stopped-flow mixing with reduced Cytc [13]. These spectral changes have the 
potential to shed more light on the nature of the proton pumping intermediates. 
Both heme a and a3 have similar midpoint potentials and strongly overlapping absorption spectra in 
the α- and Soret-band making the separation of their spectra problematic. The classical approach 
has been to first lock heme a3 fully oxidized with cyanide and then measure the difference spectrum 
of heme a [14]. The difference spectrum of heme a3 is then calculated by subtracting the heme a 
spectrum from the fully reduced-oxidized spectrum of the unligated enzyme. This revealed that the 
difference spectra of heme a and a3 in the Soret-band have nearly equal strength with peaks at 446 
and 444nm, respectively, whereas the α-band is dominated by heme a with a peak at 605nm while 
the spectrum of heme a3 is much broader and weaker [14]. The use of other ligands, including 
carbon monoxide, which locks heme a3 in the reduced form, provides very similar spectral shape 
and intensity for heme a confirming this assignment [15-16]. Early redox titrations, which probe 
intermediate levels of reduction, in both isolated mitochondria [17] and the detergent-solubilized 
enzyme [11], indicated that there were two bands of similar width to the classical spectrum of heme 
a but with equal intensity, and both components titrated with an n=1 Nernst function. One band had 
a peak at ≈603nm and a high midpoint potential whereas the other had a peak at ≈607 and a low 
midpoint potential. These were inevitably assigned to heme a and a3, respectively, in sharp contrast 
to the classical spectra. The discrepancy was partially resolved when it was determined that 
considerable redox anti-cooperativity existed between the hemes [18], such that both have a high 
midpoint potential (≈340mV) when the other heme is oxidized, and there was a strong interaction of 
≈100mV, consistent with Coulomb repulsion [19], which gives them a low midpoint potential 
(≈240mV) when the other heme is reduced. However, the origin of the spectral shift observed 
during the titrations was not resolved and was left as: “the difference spectrum peaks at 
wavelengths just below 605 nm for the oxidized to half-reduced transition, but just above 605 nm 
for the half reduced to reduced transition of the enzyme” [20]. 
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More recently, we found that the spectrum of heme a in living RAW 264.7 mouse macrophage cells 
had a peak at 602nm in the presence of a proton motive force, but shifted to the classic 605nm form 
when the proton motive force was collapsed with a proton ionophore [21]. This data allowed us to 
extract an absorption spectrum which had nearly equal width and magnitude as the classic 605nm 
spectrum but a peak at 602nm. When this spectrum was used in combination with the classical 
heme a spectrum to analyze attenuation spectra from redox titrations of CytOx in the living cells, 
we found that the 602nm form titrated as heme a when heme a3 is oxidized and the 605nm form 
titrated as heme a when heme a3 is reduced. This model was able to explain the spectral shifts 
observed previously was compatible with the anti-cooperativity between the hemes and used the 
classical heme spectra, albeit with an additional form of heme a blue shifted to 602nm. However, 
the line width of these features precludes their spectral resolution and they can only be separated 
with multiwavelength fitting requiring more precise spectroscopic measurements than needed for 
dual-wavelength difference spectroscopy. These results were met with considerable skepticism, at 
least partly due to the complex milieu of the living cell, citing the peak shift of heme a with Ca
2+
 
binding [22-24] (see [25] for a recent review) and with pH [26], and interference from the 607nm 
feature of the BNC in the F and PR state [27] due to the use of oxygen as an oxidant during the 
titrations. Here we perform precise and simultaneous spectroscopic measurements from the Soret- 
and α-band of isolated detergent-solubilized bovine cytochrome oxidase to address these criticisms 
and shed more light on the origin of the two forms of heme a. 
2. Materials and Methods 
2.1 Spectroscopy 
Attenuation measurements were made in a custom chamber containing a 2mL cuvette with a 1cm 
pathlength. The cuvette has mounted in an aluminum block and held at 37±0.01°C with an Arroyo 
Instruments 5305 5A/12V TEC Source using an AD590 temperature transducer mounted in the 
block and two 6W thermoelectric elements mounted under the block. 
Light from a 3-phosphor LED was coupled into a 1.0mm optic fiber with NA 0.37 and collimated 
with a 7.86mm focal length aspheric collimator lens with NA 0.51. The collimated beam passed 
through the cuvette and into a 19mm Teflon integrating sphere built into the aluminum block. Light 
from the integrating sphere was collected with two 1mm NA0.37 optic fibers and F# matched onto 
two F4.1 0.32m spectrographs each equipped with 600g/mm gratings and a 1024x128 pixel CCD 
cooled to 214K. One spectrograph was tuned to give spectra from 508-640nm (α-band) and the 
other from 390-580nm (Soret-band) with a 0.13nm pixel band pass. The slits were set to give a 1nm 
spectral resolution. The dispersion across the CCDs was determined from the grating equation using 
the spectrograph’s centre wavelength, the focal length of the spectrograph’s output mirror and the 
tilt of the CCD with respect to the focal plane. These 3 parameters were calibrated for each 
spectrograph using >20 lines of a low pressure neon lamp and then, daily, the center wavelength 
was calibrated with the 546, 573 and 576nm lines (α-band) or the 435nm line (Soret-band) of a low 
pressure mercury lamp. The position of the calibration lines was determined with sub pixel 
accuracy from the maximum of a quadratic function fitted to the center pixel of the peak and one 
pixel each side of the peak. The calibration accuracy was <0.01nm and the spectrograph grating was 
not rotated between calibration and measurement precluding mechanical error; the day to day drift 
in the calibration was <0.02nm. 
2.2 CytOx preparation 
Mitochondria were isolated from bovine hearts [28] then mitochondrial membranes were prepared 
by disruption with a Waring blender in the presence of KCl [29]. The final pellet was resuspended 
in 20 mM Tris-HCl (pH 7.4) with 10% v/v glycerol and 1 mM EDTA and 10mL aliquots were 
stored at −80°C. Aliquots were thawed slowly on ice and then solubilized with 1% n-dodecyl-β-D-
maltoside (DDM, Anatrace), stirred for 20 min, and then centrifuged for 23 min at 34500g. The 
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4 
supernatant was filtered and then applied to a pre-equilibrated 16 mL Q-Sepharose HP column 
(Amersham Pharmacia Biotech). Buffer A for the elution contained 20 mM Tris-HCl (pH 7.4), 10% 
(v/v) ethylene glycol, 0.1% (w/v) DDM and 0.005% (w/v) phenylmethanesulfonyl fluoride(PMSF), 
and buffer B contained 1M NaCl. The Q-Sepharose column was washed with 16 mL of buffer A 
and then CytOx was eluted as a green fraction at ≈250mM by a linear gradient to 350mM NaCl (30 
mL at 2mL min
−1
). The green fractions were pooled, concentrated with a 100 kDa Amicon Ultra-15 
centrifugal filter unit to a concentration of 60-80μM, and then frozen at −20°C until use. This 
fraction was soluble in aqueous buffers with no additional detergent. 
2.3 Equilibrium model 
The data was analyzed in terms of an equilibrium Markov state model [30-31] rather than an 
equilibrium redox model (see appendix of [32]). Both models produce precisely the same results 
when applied to the same system but the former is used because (1) it is a more fundamental 
description of the system as it is based on equilibrium statistical thermodynamics, (2) it is more 
appropriate when a redox centre can be split into multiple states based on spectroscopy and (3) so 
that these states can be used in an in-silico Markov state model of turnover at a later time. The 
states, σ, were described as <X,nH,nL> where X is the redox state of heme a and a3, nH is the 
number of protons bound and nL is the number of ligands, L, bound. Only azide was considered as a 
ligand in this study. Five redox states were included in the model: the enzyme with both hemes 
oxidized (o), with only heme a reduced having a peak at 605nm (a605) or at 602nm (a602), with only 
heme a3 reduced (a3) and with both hemes reduced (aa3). The energy of a state, 
E , is given by 
    ][Ln][Ln0 LTknHTknEnEE BLBHhe    Equation 1 
Where 

0E  is the energy of the state under standard conditions, Eh is the ambient redox potential, ne 
is the number of electrons of the state (0 for o, 1 for a605, a602 and a3, and 2 for aa3) kB is 
Boltzmann’s constant, T is the absolute temperature in Kelvin and the square brackets denote the 
concentration of the species divided by the concentration of the species under standard conditions. 
The probability of an individual CytOx protein being in state σ, P , is determined by the 
Boltzmann distribution and given by  
 
 






TkE
TkE
B
B
e
e
P  
Equation 2 
Where the denominator is the partition function which is the sum is over all states. The standard 
potential of the unligated oxidized state was set to zero. The attenuation spectrum, A(λ), of a cuvette 
with pathlength d and CytOx in a distribution of states with total concentration C is given by: 
    


  PdCA  Equation 3 
where εσ(λ) is the specific extinction spectrum of the σ state and assumed to be the sum of the 
contributions from heme a and a3. 
Where a spectroscopic signal can be attributed to multiple states, the signal is proportional to the 
sum of the probabilities of each state and an effective energy can be defined as  
    
 TkE
B
s BeTkE Ln  Equation 4 
where the sum is over all the states forming the spectroscopic signal. 
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5 
The midpoint potential for a redox couple from an oxidized state (O) to a reduced state (R), ROmE
 , 
is given by: 
 RORO
m EEE 00 
  Equation 5 
where OE0  and 
RE0  are the standard energies of the oxidized and reduced form, respectively. The Kd 
for ligand binding from an unbound state (U) to a bound state (B) is given by: 
   UBBUdB EEKTk 00Ln   Equation 6 
Where UE0  and 
BE0  are the standard energies of the unbound and bound form, respectively. 
Standard conditions are defined here as: 37°C, pH 7.0, azide 1M. Potentials are expressed in 
millivolts (mV), where 10.46mV=1KJ/mole, so that the model can be directly compared to the 
membrane potential and redox potentials of the substrates in the future. In mV, kBT = 26.7mV and 
kBT Ln(10) = 61.5mV. 
2.4 Redox titrations of detergent solubilized bovine CytOx 
Redox titrations were carried out in a 100mM potassium phosphate / potassium hydroxide buffer at 
pHs between 6.0 and 9.0 with 200μM BAPTA to chelate out any calcium ions. At pH 9.0, 100mM 
phosphate still has a buffering capacity of 3.62mM/pH unit but the actual pH of the buffer was 
measured at the end of the study with a pH electrode. High free calcium was obtained by addition of 
250μM of CaSO4. NADH was used as a reductant and 10μM phenazine ethosulfate (PES) as a 
redox mediator. Titrations were carried out using either oxygen as an oxidant or the FIRE protocol 
as a reductant [32] and the ambient redox potential was monitored from the oxidation state of Cytc 
assuming a midpoint potential of 260mV; the titration analysis was restricted to the range 2-98% 
oxidized (260±104mV).  
The 2mL cuvette was sealed from the top with a stainless steel plunger through which a length of 
fine gauge silicone tubing (OD 0.94mm, ID 0.51mm, Helix Medical Europe) was threaded such that 
it formed a 15mm loop within the cuvette. A computerized gas blender generated a nitrogen 
/oxygen gas mixture which was passed through the tubing allowing oxygen to diffuse into the 
cuvette at a rate depending on the difference in oxygen tension across the wall of the tubing. The 
cuvette was stirred with a glass-coated magnetic bead and the tubing extended the height of the 
cuvette so that the oxygen that diffused through the tubing was rapidly homogenized throughout the 
cuvette. The oxygen concentration in the cuvette was measured using a custom made phase-
flurometer from the lifetime of an oxygen-sensitive phosphorescent optode (Tau Theta, Bolder, CO) 
inserted through a hole in the side and sealed with a viton o-ring. The phosphorescent optode was 
excited with light from a filtered 385nm LED which was square wave modulated at 4KHz. The 
650nm phosphorescent emission was long-pass filtered and detected with a silicon photodiode and 
the output digitized at 1MHz. The phase was determined from the 1st harmonic, converted to a 
quench rate, and the non-linearity between quench rate and oxygen concentration was calibrated 
against a Clarke electrode. 
Initially ≈2.0μM cytochrome oxidase and ≈3.6μM of horse heart Cytc (Sigma) was added to the 
cuvette at ambient oxygenation (≈200μM) and then CytOx turnover was initiated by adding 500μM 
of NADH. Once the cuvette became anoxic, the excess NADH was then consumed by flowing 5% 
oxygen through the tubing until the Cytc oxidized and the oxygen concentration rose to ≈1μM. The 
CytOx and Cytc was reduced again with 25μM of NADH and then the oxygen in the tubing was 
increased to 2% and the Cytc swept from fully reduced to fully oxidized over a period of 7-8 
minutes while spectra were collected contiguously with a temporal resolution of 500ms. During the 
titration, CytOx immediately consumed the oxygen delivered by the tubing so that the cuvette was 
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maintained anoxic to within the noise floor of the oxygen optode (0.04μM) until the CytOx was 
almost fully oxidized (see fig. S.6 of the supplementary information). The oxygen delivery was 
estimated to be ≈1.5μM/minute so that the titration was performed at a CytOx turnover rate of 
approximately 1 oxygen every 80 seconds. This slow turnover rate should ensure that tight 
equilibrium with Cytc was maintained throughout the titration and also that CytOx was kept in the 
active form. The FIRE protocol used 1μM riboflavin as photocatalyst and 2mM of EDTA as the 
ultimate reductant with 10μM PES as redox mediator. The riboflavin was photoexcited with a pulse 
of light from a 450nm high power blue LED which was time multiplexed with the white detection 
LED using a duty cycle of 6ms on and 4ms off and a cycle time of 20ms. The CCDs were read in 
the off period after every pulse and the attenuation spectrum from the white LED was average to 
give a temporal resolution of 500ms. This allowed attenuation spectra of CytOx to be collected 
continuously, and without interference from the blue LED, as the oxidation state of Cytc was swept 
from fully oxidized to fully reduced over a period of ≈3 minutes. When a FIRE titration was carried 
out immediately after an oxygen titration, the data overlaid and the fitted midpoint potentials of the 
different states varied by <3mV (fig. S.1 of the supplementary information). This shows that the 
Cytc and the heme a and a3 of CytOx were maintained in redox equilibrium to ≈3mV during the 
titration and that the CytOx did not relax into a form with different redox properties on the 
timescale of two-titrations (≈10 minutes). 
2.4 Redox Titrations of mouse CytOx in living cells 
Titrations in RAW 264.7 mouse macrophages have been described previously [21]. In brief, cells 
were cultured in RPMI media with 10% FBS and antibiotics in a humidified 5% CO2 incubator, 
then spun down at 500g for 5 minutes and resuspended at a density of 2.0×10
7
 cells/mL in RPMI. 
Spectroscopic measurements were carried out in a custom 5mL chamber maintained at 37°C 
containing 80mm of silicone tubing through which a N2:O2:5% CO2 gas mixture was passed. The 
cells were made anoxic and then the proton motive force collapsed with a combination of 5ug/mL 
of oligomycin and 2uM of the protonophore BAM15. The cells were then treated with 1μM of 
rotenone to inhibit complex I and the gas mixture in the tubing increased to 2% to initiate oxidation 
of the succinate/fumarate pool via complex II, complex III and complex IV. This procedure swept 
Cytc from almost fully reduced to almost fully oxidized over a period of 2 minutes as the succinate 
pool was depleted. The oxygen in the tubing was then returned to 0% and the Cytc re-reduced. The 
cells were then treated with 1mM of sodium azide and a second titration carried out by switching 
the oxygen in the tubing to 2%. The ambient redox potential was monitored from the oxidation state 
of Cytc in the range 5-95% (260±79mV) assuming a midpoint potential of 260mV and data 
collection was every 500ms allowing the collection of ≈200 data points in the titration range of 
Cytc. 
2.5 Spectral Fitting 
Attenuation spectra were fitted to a model consisting of a linear combination of the chromophores 
and a polynomial background, e.g. 
     n
nnc cc
aCA     Equation 7 
Where ρ is the pathlength, ΔCc is the change in oxidation of the c
th
 chromophore, εc(λ) is the 
specific absorption spectrum of the c
th
 chromophore, the first sum is over all chromophores and the 
second sum is a polynomial background. The fitting range was 520-630nm for the α-band and 405-
480nm for the Soret-band. 
The reference difference (oxidized-reduced) spectra for heme a3 and heme a605/446 (heme a with a 
peak at 605nm and 446nm in the α- and Soret-band, respectively) was from Liao and Palmer [14] 
and the tabulated data downloaded from the author’s website. The spectrum of heme a602 and a443 
were obtained by blue shifting the heme a605/446 spectrum by 3nm. The isolated enzyme was fitted 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
7 
with the difference spectra of a605/443, a602/443, a3 and horse heart Cytc with a linear background. The 
mouse cells were fitted with the difference spectra of a605, a602, a3, mouse Cytc, bH, bL and c1 with a 
quadratic background to correct for small changes in scattering coefficient of the turbid media. 
The spectral component of Cytc was removed from the change in attenuation spectra by subtracting 
ρΔCε(λ) where ΔC is the fitted change in oxidation of Cytc and ε(λ) is the specific absorption 
spectrum of Cytc. 
2.2 Measurement of spectral shifts 
From the definition of the first differential, the spectrum of a feature shifted by δλ is approximated 
by:  
 
    



d
d
  
Equation 8 
Where ε(λ+δλ) and ε(λ) are the shifted and unshifted spectra, respectively, and dε/dλ is the first 
differential of the unshifted spectrum with respect to wavelength, λ. The spectrum of dε/dλ is 
included into the fitting model as a pseudochromophore and the effective change in concentration 
(ΔCc) from the fitting is the product of the pathlength, change in concentration of heme a and the 
wavelength shift. The wavelength shift can then be calculated by dividing by the change in heme a 
concentration. 
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3. Results 
3.1 The spectral shift in the α-band. 
Figure 1 shows changes in the α-band attenuation 
spectrum of detergent solubilized bovine CytOx on 
reduction from the oxidized state at pH 8.0 when the 
calcium was chelated with BAPTA. The component of 
Cytc was spectrally subtracted (see Methods) to allow a 
clearer view of the spectral shift of the α-band (see fig. 
S.2 of the supplementary information for the original 
spectra). The α-band peak first appears at ≈603nm, then 
undergoes a red shift to ≈604nm at an ambient redox 
potential of 200mV and finally shifts to 605nm when 
fully reduced (fig. 1). The inset of fig. 1 shows the 
spectrum at a redox potential of 280mV (when heme a is 
half reduced) minus the fully oxidized spectrum in red, 
which has a peak at ≈603nm, and the fully reduced 
spectrum minus the spectrum at 280mV (blue), which 
has a peak at ≈607nm. This data confirms “the 
difference spectrum peaks at wavelengths just below 605 
nm for the oxidized to half-reduced transition, but just 
above 605 nm for the half reduced to reduced transition 
of the enzyme” [20]. 
To further investigate the spectral shifts, we performed 
titrations at different pHs in the presence and absence of 
calcium. The full-width at half-maximum of the heme a 
spectrum is broad (approximately 17nm) making it difficult to precisely quantify small spectral 
shifts directly from the spectrum. Therefore, the reference spectrum and its first differential were 
first fitted to the attenuation spectra and then the spectral shift relative to the reference spectrum 
was calculated from the relative magnitude of the two 
components (see methods). This technique is expected to 
be highly accurate for heme a when the peak-shift is 
small (<±2nm) but likely to underestimate it when the 
peak shift is larger. Using this technique on the 
attenuation spectra, we found that, when the adventitious 
calcium was chelated with BAPTA, the blue shift at 
intermediate redox potentials is greater at high pH (fig. 
2, blue traces) and the peak position of the fully reduced 
CytOx is also pH dependent above pH ≈7.5 (fig. 2 inset). 
Also, this technique was sensitive enough to show that, 
in the fully reduced enzyme at a pH range of 6.0-7.5, 
where the α-band position is independent of pH, the 
precise position of the α-band varies by 0.2-0.5nm from 
the reference spectrum depending on the isolation batch 
(data not shown). Previously it has been demonstrated 
that binding of calcium to the cation binding site red-
shifts the α-band of both the fully reduced enzyme [22] 
and cyanide-inhibited mixed valence bovine enzyme 
[22-24]. As shown in fig. 2, calcium binding also red 
shifts the heme a band at intermediate redox potentials 
(red traces), although to a lesser extent than blue shift 
 
Figure 2. Wavelength shift of the α-band of 
heme a as a function of redox potential at 
increasing pHs (7.0, 7.5, 8.0, 8.5 and 9.0). Blue 
and red traces indicate the absence of calcium 
(chelated by 200μM BAPTA) and presence of 
calcium (addition of 250μM CaSO4), 
respectively. Inset: wavelength shift when fully 
reduced. Green bars are the shift on calcium 
binding to the fully reduced enzyme. 
 
Figure 1. Changes in the α-band attenuation 
spectrum of CytOx on reduction from the 
oxidized state at pH 8.0. The black vertical lines 
are drawn at 605nm to emphasize the small 
spectral shifts. The inset shows the spectrum at a 
redox potential of 280mV (half reduced) minus 
the fully oxidized spectrum (red) and the fully 
reduced spectrum minus the spectrum at 280mV 
(blue). 
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from the reference spectrum. The α-band peak position 
of the Ca-bound fully-reduced enzyme remains pH 
dependent (fig. 2 inset) but the red-shift on calcium 
binding (green bars) is independent of pH (mean±SD of 
0.43±0.06 nm) indicating that the red-shift with calcium 
is additive to the blue-shift with pH. 
3.2 Blue shift in the Fully Reduced Enzyme. 
To further investigate the origin of the blue shift with pH 
of the fully reduced enzyme in the absence of calcium 
(inset of fig. 2), the difference attenuation spectra at 
different pHs were fitted to a spectral model that 
consisted of: the Cytc difference spectrum, the reference 
heme a difference spectrum (a605), the reference heme a3 
difference spectrum (a3) and the reference spectrum of 
heme a blue-shifted by 3nm to have a peak at 602nm 
(a602). It was found that, at high pH, the peak shift in the inset of fig. 2 can be attributed to an 
increased fraction of the 602nm form of heme a (fig. 3). This conversion from the 605 to the 602nm 
occurred with a pKa of ≈9.4, as determined by fitting a disassociation curve to the fraction of each 
spectral component in the reduced spectrum (fig. 3). Usually, it is difficult to determine a pKa if the 
data points do not cover the plateau above and below the pKa [25] but it is more reliable in this case 
because the probability, and hence the extent of the change, is known.  
3.3 Spectral components of the α-band 
To explore the origin of the spectral shifts at intermediate redox potentials, the attenuation spectra 
from a redox titration of the detergent-solubilized bovine CytOx was fitted with the Cytc, a605, a602 
and a3 spectral components, and the signal of the heme components were plotted as a function of 
the redox potential of Cytc (fig. 4a). While the spectral fitting algorithm could not successfully 
separate the heme a3 spectral component in the mouse cells (because the absorption is weak, broad 
and nearly collinear with the quadratic background used to correct for small baseline offsets) this 
could be achieved in the cleaner spectral environment of the detergent-solubilized enzyme. The 
spectral components of the α-band at different redox potentials are shown in fig. S.3 of the 
 
Figure 4. Redox titrations of the α-band of CytOx at pH 7.5. The experimental data is shown as points, the lines are a fit 
to a redox model and the spectra for the fitting model are shown in the insert. a) Titrations from the α-band using the 
standard a605 and a3 spectra along with the a602 spectrum. The data was fit to a 5 state model of redox cooperativity. b) 
The same spectra data as a) but fitted using a linear combination of the a605 and a602 spectra which titrate as n=1 Nernst 
functions (lines). c) Titrations from the Soret-band using the reference spectrum of heme a (a446) and a3, and the 
reference spectrum of heme a blue shifted by 3nm (a443). The lines are from the model in a) shown to emphasize the 
differences between the data obtained from the α- and Soret-bands. 
 
Figure 3. The fraction of the a605 and a602 spectra 
to the attenuation spectrum of fully reduced 
CytOx as a function of pH. CytOx was reduced 
with NADH, using PES as a redox mediator, and 
in the presence of 200μM BAPTA to chelate 
calcium. Data points are from 3 studies and the 
lines are from a disassociation function with a 
pKa of 9.4. 
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supplementary information where it can be seen that the a605 and a602 components merge together to 
form the α-band and are never spectrally resolved. The attenuation spectrum is dominated by the 
602nm form as the ambient redox potential is reduced from the oxidized state to 280mV (fig S.3) 
but with a small contribution from the 605nm form and a3 such that the compound spectrum has a 
peak at ≈603nm (inset of fig. 1). On further reduction from 280mV to the fully reduced state, the 
602nm component is lost and the spectrum becomes dominated by the 605nm component with 
weaker intensity from the a3 spectrum. In this range, the loss of absorption at 602nm and the 
increase at 605nm together with the broad a3 spectrum leads to a compound difference spectrum 
with a peak at ≈607nm (inset of fig. 1). Fig. S.4 of the supplementary information confirms that the 
α-band cannot be successfully fitted without the 602nm spectral component, as was previously 
found in the mouse cells. 
The signal of each component was first compared to a standard redox model of the two hemes with 
anti-cooperativity. This model contained 4 states: the o state with both hemes oxidized, the a state 
in which only heme a is reduced, the a3 state in which only heme a3 is reduced and the aa3 state in 
which both hemes are reduced. The states with only one heme reduced (a and a3) in a two-center 
anti-cooperativity model titrate with the same bell-shape but with different magnitudes depending 
on the relative midpoint potential whereas the state with both hemes reduced (aa3) titrates with a 
shape similar to an n=1 Nernst function (fig. S.5 of the supplementary information). As in the case 
of redox titrations in living RAW 264.7 mouse macrophages treated with oligomycin and CCCP to 
collapse the proton motive force, the signal from the a602 spectral component has a bell-shape very 
similar to the a and a3 states of the redox model and the signal from the a605 spectral component has 
a shape similar to an n=1 Nernst function (fig 4a). However, the model could not achieve a good fit 
to the data because the a605 signal had greater probability at redox potentials near the peak of the 
bell curve where only one heme is reduced than would be predicted if it only originated from the 
aa3 state (fig S.5 of the supplementary information and the analysis therein). Therefore the a-state 
of the four state model was split into two states, one with the a605 spectrum and one with the a602 
spectrum. This redox model consisted of 5 states: an o state with both hemes oxidized, an a605 state 
with only heme a reduced having the a605 spectrum, an a602 state with only heme a reduced but 
having the a602 spectrum, an a3 state with only heme a3 reduced and the aa3-state with both hemes 
reduced; the a605 state was not needed previously in the redox model of the mouse cells to obtain a 
good fit. The a605 signal was assumed to arise from the a605 and aa3 states, the a602 signal from the 
a602 state and the a3 signal from the a3 and aa3 states. The heme a signal is the sum of the a605 and 
a602 signals. The resultant model provided a good fit to the data (fig. 4a) with both heme a (effective 
midpoint potential of the a602 and a605 states calculated with equation 4) and a3 titrating with 
midpoint potentials of 330mV when the other heme is oxidized and 225mV when the other heme is 
reduced at pH 7.5, in good agreement with the values of 340 and 240mV obtained from previous 
magnetic circular dichroism studies [33] at pH 7.4. It should be noted that this redox model could 
account for the signal from both heme a and a3 and that there are no invisible components in the 
model. 
At any instant an individual CytOx complex is in a single state (e.g. heme a is either oxidized or 
reduced but cannot be half reduced). However, the cuvette contains many individual CytOx 
complexes and therefore the number of CytOx complexes in each state is determined by a 
probability distribution (equation 2). The attenuation spectrum of the cuvette is expected to be the 
algebraic sum of the absorption spectra of the individual CytOx complexes in the cuvette - and so 
will be the algebraic sum of the spectrum of each state weighted by the probability of finding 
CytOx in each state (equation 3). For example, the spectral model used to generate fig. 4a shows 
that 27% of the CytOx have heme a reduced with the a602 spectrum, 33% have heme a reduced with 
the a605 spectrum and 53% have heme a3 reduced at an ambient redox potential of 250mV at pH 7.5. 
Similar to fig. S.3 of the supplementary information, the resulting attenuation spectrum has a peak 
at 603.6nm. The redox model shows that 27% of the CytOx are in the a602 state, 17% are in the a605 
state, 37% are in the a3 state and 16% are in the aa3 state.  
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Due to the nature of linear algebra, when a spectrum can be well-fitted with one set of basis spectra 
then it can be equally well-fitted with any linear combination of the basis spectra. Furthermore, in a 
two-center redox model with strong anti-cooperativity, the aa3 state titrates with a shape very 
similar to an n=1 Nernst function with a midpoint potential 19mV below the midpoint potential for 
the second electron in an anti-cooperativity model, as does the sum of the aa3, a3 and a states with a 
midpoint potential 19mV higher than that for the first electron (see Titration functions and basis 
spectra of the supplementary information). Thus, by carefully choosing two linear combinations of 
the a602 and a605 spectra to form two new basis spectra, it was possible to fit the attenuation spectra 
such that the resultant signals from the two new basis spectra follow the aa3 state and the sum of the 
aa3, a3, and a states and both titrate as n=1 Nernst functions. For the conditions of figure 4a, the 
new basis spectra are approximately half the a602 spectrum and the a605 spectrum minus half the a602 
spectrum. Both spectra are approximately half the magnitude of a605 spectrum (inset of fig. 4b) and 
have peaks at ≈602 and ≈607nm, respectively. When these spectra are used to fit the same data as in 
figure 4a, the signals titrate as n=1 Nernst functions with midpoint potentials of 350 and 210mV, 
respectively, as predicted. 
Importantly, spectral shifts of heme a were also observed in the Soret band and, to a lesser extent in 
heme a3. The technique of using the differential of the absorption spectra to quantify spectral shifts 
could not be used because the spectra of heme a and a3 are too similar. Instead, the reference heme 
a spectrum was blue shifted to give the Soret equivalent of the a602 spectrum. The shift in the 
energy of the α-band optical transition is 82 wavenumbers and this would equate to a shift of 
1.64nm at 446nm. However, the shift which gave the best correspondence between the α-band and 
the Soret band was found by trial and error to be ≈3nm, almost twice the shift in energy (152 
wavenumbers). This difference in energy could be because the Soret- and α-band transitions 
originate from different unoccupied molecular orbitals .When this ad hoc spectrum (a443) was used 
with the a446 , the a3 and the Cytc spectrum to fit the Soret data, the a446 and a443 components 
titrated in close correspondence with the a605 and a602, respectively, at pH 7.5 (fig 4c), and there was 
good agreement between the Soret and α-band heme a3 components, confirming that the spectral 
shift is a property of heme a and not an artifact of the α-band spectroscopy. This good 
correspondence was maintained at pH8.0 and below but was poorer at pH 8.5 and 9.0 (fig. S7 of the 
supplementary information). 
3.4 pH Titrations 
Previously we suggested that the a602 form is generated on the uptake of the pumped proton [21] 
and so, to further investigate this, redox titrations were carried out in the pH range 6.0-9.0 to 
separate the protonated and unprotonated forms. The titration at each pH could either be fitted with 
5 redox states (o, a602, a605, a3 and aa3) to give effective midpoint potentials at each pH, or all the 
titrations could be fitted simultaneously to a model which included the 5 redox states, each with 1 or 
more protonation sites. The 5(N+1) standard energies, where N is the number of protonation sites, 
were varied using a Levenberg Marquardt algorithm [34] until the least square difference was 
minimized between the predicted and measured probabilities of the a602, a605, a and a3 spectral 
State E0 (0H
+
) E0 (1H
+
) E0 (2H
+
) pKa  0→1 pKa 1→2 
o 0 -33.2±7.8 68.8±18.6 7.54±0.13 5.34±0.43 
a602 -317.5±1.1 -344.6±4.3 -297.1±4.7 7.44±0.09 6.23±0.03 
a605 -235.9±16.5 -349.0±4.4 -275.6±4.4 8.84±0.34 5.81±0.11 
a3 -236.4±8.6 -370.3±4.8 -286.1±9.9 9.18±0.07 5.63±0.08 
aa3 -510.2±2.6 -596.0±3.7 -536.1±6.4 8.39±0.10 6.03±0.05 
Table 1 Standard energies for unprotonated, singly protonated and double protonated states, and pKas for the model of 
fig. 4. Values are expressed as mean±SD (n=3 sets of titrations with each set having 7 pHs). 
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components at all pHs. Whereas a reasonable fit was obtained with one protonation site, there were 
some small inaccuracies at low pH (data not shown) and a much better fit could be obtained with 
two protonation sites (fig. 5). These two protonation 
sites are in addition to the site with a pKa of 9.4 that 
blue-shifts the fully reduced enzyme. That site was not 
included in the model of the redox titrations because it is 
only apparent at high pH, and at redox potentials that are 
too low to be quantified from the oxidation state of Cytc. 
The standard energies and pKa of the two binding sites 
are given in table 1 and the pH dependence of the 
standard energies of the redox states for the data in fig. 5 
are shown in fig. 6a.  
The predicted pH-dependent midpoint potentials 
calculated from the standard energies for the 4 redox 
couples are shown as lines in fig. 6b and compare well 
with the midpoint potentials when the data from each pH 
titration was fitted to a 5 state model separately (circles). 
The midpoint potentials of heme a3 and heme a when it 
has a peak at 605nm (states a3 and a605, respectively) are 
strongly pH dependent for the first electron. In contrast 
heme a with a peak at 602nm for the first electron (state 
a602), and heme a for the second electron (state aa3), 
which has a peak at 605nm, is only weakly pH 
dependent.  
Fig 6c shows the numbers of protons bound to each state 
as a function of pH. In the pH range from 7.0 to 8.0, 
reduction of the oxidized state to the a602 state does not 
increase the total number of protons bound, however, 
reduction to the a605 state takes up between 0.2 and 0.6 
protons depending on the pH. The a3 state can only be 
 
Figure 6. pH dependence of a) the standard 
energies, b) midpoint potentials and c) number of 
bound protons of the 15-state model fitted to the 
data of fig. 5. The data points in b) are the 
midpoint potentials of a 5 state model fitted 
individually to the data at each pH. 
 
Figure 5. Redox titrations of the α-band of CytOx at increasing pH (6.0 to 9.0). The experimental data is displayed as 
points and the lines are a fit to a 15-state (o, a602, a605, a3 and aa3 with 0, 1 or 2 bound protons) model with the standard 
energies fitted simultaneously to all the data points. 
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populated when protonated in this pH range, presumably at the BNC. Surprisingly, entry of the 
second electron to the a3 state to form the aa3 state is accompanied by the release of protons, even 
though the net charge on heme a and a3 has become more negative. Also shown in fig. 6c is the 
difference in the numbers of protons bound between the fully reduced enzyme (aa3) and the 
oxidized enzyme (o) estimating that ≈0.4 protons are taken up on full reduction in the pH range 7.5-
8.0. 
3.5 Redox titrations in the presence of Azide 
Azide induces a blue-shift in the α-band of CytOx during turnover which is reversed when the 
enzyme becomes anoxic [35]. This blue-shifted spectrum is similar to a602 prompting us to examine 
the effect of azide binding on redox titrations. These titrations were carried out with the FIRE 
protocol as azide binds at the BNC and inhibits the reduction of oxygen. As shown in fig. 7, azide 
stabilizes the a602 state and drives the aa3 transition to lower redox potentials, similar to the effect of 
high pH. 
Attempts to fit the 5 states with one ligand binding site to this data consistently resulted in 
extremely high Kd of the ligated a605, a3 and aa3 states, meaning that the azide did not bind at the 
concentrations used. The redox model with the remaining 7 states (unligated o, a602, a605, a3 and 
aa3, and single ligated, o and a602) gave a Kd of 910μM and 670μM to the o and a602 states, 
respectively, but did not result in a good fit to the data, particularly at low azide concentrations 
(data not shown). Therefore a second ligand binding site was added to the model which provided 
the fits shown in fig. 7. This model consisted of 12 states: unligated and single ligated o, a602, a605, 
a3 and aa3 and double ligated o and a602. The Kd for binding of the first azide to o, a602, a605, a3 and 
aa3 was ≈80, 90, 390, 3600 and 910μM, respectively, and the Kd for binding the second azide to o 
and a602 was ≈10.0 and 6.6mM, respectively. Fig. 8 compares the concentration-dependent midpoint 
 
Figure 7. Redox titrations of the α-band of CytOx at increasing concentrations of sodium azide (pH 8.0). The points are 
the data and the lines are from a simultaneous fit to a redox model which consisted of unligated and singly ligated o, 
a602, a605, a3 and aa3, and doubly ligated o and a602. 
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potentials calculated from this 12-state model (solid 
lines) to the midpoint potentials calculated from a 5-state 
model fitted to the titration data at each concentration 
(triangles). The dotted lines are the predicted midpoint 
potentials of the 12 state model but if only the first 
binding site is considered and shows that the midpoint 
potentials of the azide-bound and -unbound redox 
couples for the first azide binding are remarkable similar 
to those of the protonated and unprotonated redox 
couples for the first proton (table a and fig 6b). 
3.6 Redox titrations from CytOx in living RAW 264.7 
mouse macrophages 
To determine if azide had the same effect to stabilize the 
a602 state in mouse cells, redox titrations were carried in 
the absence or presence of 1mM azide. These titrations 
were performed with the same methodology, using 
oxygen as an oxidant under anoxic conditions, but the 
proton motive force was first collapsed with a 
combination of oligomycin and a protonophore. The 
turnover number of CytOx was approximately 1.1±0.3 
O2/CytOx/s (mean±SD n=4) during the titrations. The 
signal to noise was poorer in mouse cells, mainly 
because only 50nM of CytOx is present as opposed to 
the 2μM in the isolated enzyme preparations, but 
otherwise the data was similar: the azide stabilizes the 
a602 state and drives the transition of the aa3 state to a 
lower redox potential. The midpoint potentials for these 
titrations are given in table 2 and compared to the 
midpoint potentials from the bovine enzyme in fig. 8. 
4. Discussion 
4.1 Spectra shifts 
Spectral shifts in the α-band are a common observation 
but the most studied effect has been observed with 
calcium [22, 25-26] which binds reversibly in the bovine 
enzyme at a specific site in subunit I on the cytosolic 
side of the enzyme [23]. Binding red-shifts the heme a 
 
Figure 9. Redox titrations of the α-band of 
CytOx from living RAW 264.7 macrophages in 
the absence and presence of 1mM of sodium 
azide. 
Em +FCCP −Azide +Azide 
o→a602 329.9±4.3 325.4±3.0 333.3±2.4 
o→a605 251.2±19 297.6 ±2.2 <230 
o→a3 292.9±2.9 315.7±7.3 283.0±6.1 
a3→aa3 223.9±7.9 243.9±3.2 243.3±5.9 
Table 2. Midpoint potentials (Em) for a 5 state redox model to 
redox titrations carried out in RAW 264.7 mouse macrophages in 
the presence or absence of 1mM azide. +FCCP reanalysis of the 
FCCP treated data from [21] in the absence of azide. Values are 
presented as mean±SD (n=6, 4 and 4, respectively) 
 
Figure 8. Effective midpoint potentials in the 
presence of azide. The solid lines are the 
predicted midpoint potentials from the redox 
model with both binding sites and the dotted 
lines are the midpoint potentials for only the high 
affinity site. The triangles are the midpoint 
potentials of a 5 state model fitted individually to 
the data at each pH. The circles are the midpoint 
potentials from the mouse cells. 
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spectrum and produces a characteristic difference spectrum that can easily be used to quantify the 
Kd (≈3μM in a 100mM KCl buffer [25]). A shift of 0.54nm has been calculated in the Soret-band 
[36] but, as far as we are aware, the magnitude of the spectral shift has not been previously 
quantified in the α-band [22-26]. We find that the red shift is ≈0.4nm in the α-band and so reversal 
of calcium binding cannot account for the blue shift of 3nm of heme a recorded in the mouse cells 
at high proton motive force. Furthermore, the shift with calcium is additive to the shift found during 
both redox titrations and in the fully reduced enzyme, suggesting that the two shifts must originate 
from a different mechanism. A red shift with a similar difference spectrum to that of calcium was 
originally observed with pH [26] but this was later attributed to binding of adventitious calcium at 
low pH when EDTA loses its effectiveness [25]. Here we found that heme a of the fully reduced 
enzyme underwent a blue shift at high pH and that, on fitting the attenuation spectra with the a602 
and a605, this blue shift could be attributed to a transition from the 605 form to the 602 form with a 
pKa of 9.4. These results are different from Vygodina et al. [25] who saw a blue shift at low pH 
with a pKa of 5.4 when the oxidase underwent an acidification from pH 8.6. Their shift appeared 
over a timescale of 3-5 minutes and could not be reversed; we did not measure reversibility due to 
the difference in methodology but were able to carry out multiple redox titrations suggesting that 
the shift is reversible. Both studies were carried out in the presence of BAPTA to ensure chelation 
of adventitious Ca
2+
 at low pH but the buffers, temperature and reducing agents were different. 
The F and PR forms of the BNC have a spectral feature at 607nm [27, 37] that would be similar to 
the difference between a605 and a602. The midpoint potential of these intermediates is very high [38] 
and they would be reduced to O at a rate kinetically limited either by the transitions themselves 
(τ≈3ms in the fully reduced enzyme [39]) or electron entry from Cytc in the mixed valence enzyme. 
Cytc is maintained in close equilibrium with CuA during turnover of the isolated enzyme [40], such 
that the forward flux must be much higher than the net flux (turnover rate). When an individual 
CytOx reacts with oxygen to form the F state in our titrations, it would be able to rapidly draw 
electrons from the Cytc pool and re-equilibrate. As the re-equilibration time is much shorter than 
the turnover time, then the probability of finding an individual CytOx with the BNC in the F or P 
states would be vanishing small; no evidence of the 607nm feature, or the 580nm feature associated 
with P form of the BNC has been observed during turnover of the isolated enzyme [40]. An 
exception to this would be when Cytc is highly oxidized so that the forward flux drops to low levels 
slowing the rate of re-equilibration. We do observe a weak spectral feature at low pH during 
oxidizing titrations when Cytc is >99% oxidized (fig. S.4 of the supplementary information) but it 
has a spectrum very similar to reduced heme a3. However, this occurs outside the range of the 
titrations (Cytc 2-98% oxidized) where the a602 component is observed. Although the concentration 
of Cytc is only 70nM in the cell titrations, the cells only occupy 1% (V/V) of the suspension and, if 
it is assumed the intermembrane space only occupies 1% of the cell, then the concentration of Cytc 
in the intermembrane space is expected to be ≈ 700μM. This is much higher than in the isolated 
studies (4μM) and would maintain a high forward flux and fast re-equilibration times to much 
higher oxidation states. Finally, the a602 spectral component is necessary to account for the observed 
spectral changes even in the reducing (FIRE) titrations which are carried out under anoxic 
conditions. 
The mechanism that generates the spectral shift from 605 to 602nm in heme a is not known but it 
cannot simply be dependent on the oxidation state of heme a3 because both the a605 and the a602 
states have heme a3 oxidized. Likewise both azide and cyanide stabilize heme a3 in the oxidized 
state but azide stabilizes the 602nm form of heme a (fig. 7) and cyanide stabilizes the 605nm form 
[32]. The shift is not caused by uptake of a proton, but it could possibly be due to some interaction 
with the oxidation state of CuA or CuB, or some internal reorganization of the protein such as a 
conformational change, uptake of water or internal movement of a proton. 
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4.2 Spectral components of the α-band 
The data and analysis presented here show that the spectral shifts in the α-band of CytOx (fig. 1 and 
2) can be either accounted for with our spectral fitting model containing the classical spectra of 
heme a and a3 combined with an addition form of heme a with a peak at 602nm (fig. 4a), or a 
spectral fitting model containing the classical spectrum of heme a3 and two spectra of half the 
intensity but similar width to the classical spectrum of heme a with peaks at 602 and 607nm (fig. 
4b). The first spectral model is consistent with a redox model in which the hemes titrate with 
considerable redox anticooperativity whereas the second spectral model, previously referred to as 
the 50:50 model [20], is consistent with a redox model in which the two spectral components titrate 
as n=1 Nernst functions. The two different spectral models can fit the same spectral data equally 
well due to the linear relationship between the component absorption spectra and the resulting 
compound attenuation spectra, and rules out using the quality of the fit as a criterion to determine 
the correct model.  
However, the second model cannot be fitted with a single set of basis spectra; indeed the linear 
combination of a605 and a602 needed to generate basis spectra which titrate as (n=1) Nernst functions 
changes as the midpoint potentials change with the pH or ligation of azide. In contrast our model 
uses a single set of basis spectra to fit all the data. Furthermore, our model not only accounts for the 
spectral shifts observed during a redox titration but is also reproduces the anti-cooperativity 
between the hemes observed with numerous other techniques [20], albeit with a more sophisticated 
redox model which splits the state with only heme a reduced into two states with different spectral 
properties. Furthermore the combination of our spectral and redox models can predict the 
attenuation spectra collected by Wilson et al. [10, 17] and Hellwig et al. [11] and explain how these 
spectra could be incorrectly interpreted resulting in n=1 Nernst functions, further confirming the 
accuracy of our model and the presence of a 602nm form of heme a.  
Previously when our spectroscopy model was applied to redox titrations in mouse cells [21], we 
found that the 602nm component titrated as the a3 state and the 605nm component titrated as the 
aa3 state in a 4 state (o, a, a3 and aa3) anti-cooperativity model. As heme a has a high midpoint 
potential in the a state and a low midpoint potential in the aa3 state, we assigned these two 
components as heme a with high and low midpoint potential, respectively. In this paper, we repeat 
the same studies in the detergent-solubilized bovine enzyme and find similar results. The 602nm 
component broadly titrates as the a state and the 605nm component broadly titrates as the aa3 state, 
except that we needed to include an additional with only heme a reduced and having the 605nm 
spectral component to get a good fit to the data (see fig. S.5 of the supplementary information). This 
additional state also has a high midpoint potential at low pH and so the nomenclature of high and 
low potential is not warranted. When the original mouse cell data was re-analyzed with a 5-state 
model (o, a602, a605, a3 and aa3), the a605 state had a midpoint potential of 250±18mV and so it made 
negligible contribution to the titration. We repeated the titrations in newer cells with the same 
methodology and found that the CytOx behaved very similarly to bovine enzyme; here the a605 state 
had a much higher Em of 298mV and so made a considerable contribution to the titration. 
Furthermore, the midpoint potentials of the mouse cells were similar to those of the bovine enzyme, 
albeit all about 10mV higher. The reason for the difference in behavior of the 2 cell cultures from 
the same cell line is currently not known. It could be speculated that the difference is due to post 
translational changes that are not being controlled for, between the two cultures. 
4.3 Proton coupling 
During the catalytic cycle, the enzyme has access to a large number of states and passes through 
many of those states depending on the rate constants connecting the states. During a redox titration, 
the enzyme has access to the same states as during catalytic turnover but spends most of its time in 
the lower energy states. A key difference between a titration and catalytic turnover is that the 
enzyme has time to relax into lower energy states which are kinetically forbidden on the timescale 
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of catalytic turnover. It is well known that the isolated enzyme can relax into such states where 
electron transfer to the binuclear centre is much slower than necessary for turnover, and that the 
relaxed (slow) enzyme can be returned to the active enzyme by reduction and catalytic turnover 
[41]. These studies were specifically designed to maintain CytOx in the active form. Firstly, 
titrations were always preceded by catalytic turnover to consume the oxygen and make the cuvette 
anoxic. Secondly, the titrations in the oxidizing direction had catalytic turnover, albeit at a very 
slow rate. Thirdly, the titrations were carried out in a few minutes rather than hours to minimize 
possible relaxation. Indeed the observation that titrations in the oxidizing and reducing direction 
overlaid (see fig S.1 for the supplementary information) is strong evidence that the titrations were 
slow enough to maintain equilibrium between Cytc and heme a3 yet fast enough to prevent the 
enzyme relaxing into the slow form. Further evidence for the lack of relaxation is that the titrations 
in the isolated bovine enzyme were very similar to those in the living mouse cells where this 
relaxation into the slow form is not expected to occur. Our data should thus provide information on 
the lowest energy (highest midpoint potential) states that the enzyme passes through during 
catalytic turnover. 
Since the redox titration analysis is sensitive to protonation events which are coupled to the redox 
centers, they can be used to calculate the pKa of each site and the number of coupled protons that 
are bound at a particular pH. Two protonation sites were required to fit the data but it is likely that 
each of these sites is a mixture of atomic sites that can be protonated in a mutually exclusive 
manner. The reaction of the fully reduced enzyme with oxygen to form the oxidized enzyme takes 
up ≈1.6 protons in the pH range 7.5-8.0 [7, 42] so that reduction of the oxidized- to the fully 
reduced-enzyme must take up ≈2.4 protons given the reduction of oxygen requires 4 substrate 
protons. Of these 2.4 protons, one was assigned to the reduction of CuB, one to reduction of heme a3 
and the remaining 0.4 to the reduction of CuA [7]. We find that reduction of heme a3 from the o-
state is accompanied with a proton in this pH range (fig. 6c). However, only ≈0.6 protons are taken 
up on reduction of heme a3 because the o state already has ≈0.4 protons bound, which presumably 
are bound at a different site and ejected to the p-side upon reduction. Surprisingly, subsequent 
reduction of heme a to form the fully reduced enzyme leads to the loss of ≈0.1 protons, which is 
counter to notion of the electrostatic coupling of electrons and protons [7, 43]. There is evidence in 
the atomic structure for such an event: the carboxyl of Asp51 moves from a site buried in the 
membrane in the oxidized crystal structure, where it is in a polar but non-aqueous environment and 
expected to have a high pKa, to a site at the surface in the reduced structure where it is in an 
aqueous environment and expected to have a low pKa [44]. In addition, infrared spectroscopy also 
shows deprotonation of a carboxyl on reduction [45-46]. The net result is that reduction of both 
hemes is coupled to the uptake of only 0.4 protons rather than one. Of the other two protons, one is 
probably coupled to reduction of CuB and the other must either be coupled to CuA, CuB or both. 
The midpoint potentials of the o→a605 and o→a3 redox couples were strongly pH dependent above 
pH 7.0. At high pH, when the interacting proton has been drawn off, the midpoint potential of these 
couples is lower than that of heme a when heme a3 is reduced (a3→aa3 couple). This is contrary to 
a simple electrostatic model of anti-cooperativity [19], where the hemes inherently have a high 
midpoint potential which is then lowered when the other heme is reduced, due to the electrostatic 
repulsion. Instead the data suggests that these couples inherently have a low midpoint potential 
which is raised by interaction with a proton. The midpoint potential of the o→a602 couple is 
remarkably independent of pH above pH 7.0 because the pKa for the first proton binding event is 
similar to that of the o state. This would suggest that heme a gains a high potential in this state, and 
presumably its spectral shift, by a mechanism not dependent on proton uptake. 
4.4 Azide 
Previous studies examining small changes in the absorption spectrum of the oxidized enzyme in the 
Soret band upon binding of azide at pH 8.0, found a high affinity site with a Kd of 64μM and a low 
affinity site with a Kd of 20mM [47]. The high affinity site had a band at 2051cm
−1
 in infrared 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
18 
spectra [47-48] and the low affinity site at 2041cm
−1
 [48], both consistent with the bound N3 anion 
rather than neutral HN3. The band from the low affinity site splits on isotopic labeling of azide 
indicating that it is bound to a metal ion whereas the high affinity site does not, suggesting it binds 
to the protein [48]. Both bands are lost on addition of cyanide [47-48], even though only one 
cyanide binds per enzyme [48]. The crystal structure of bovine oxidase shows two bound azides, 
one at the BNC and one on the periphery of subunit 1 approximately 16Å from both hemes where it 
is hydrogen bonded to Tyr379 and Asn422 [49]. A re-analysis of two-wavelength titration data in 
terms of the redox anti-cooperativity [50] found that the Kd for binding when heme a3 was reduced 
was extremely high, suggesting that azide had the effect of stabilizing the a602 state and that 
reduction of heme a3 at very low redox potentials required the ejection of azide [50]. We were able 
to study the binding of azide with more detail and resolved two binding events. The disassociation 
constants for binding to the oxidized state were consistent with those measured from the changes in 
the absorption spectrum [47]. The Kd for binding of azide to the a602 state for the low and high 
affinity sites were similar to those of the o state but the Kd of binding to the a605, a3 and aa3 states 
was considerably increased for the high affinity site and increased to such an extent for the low 
affinity site that it could not be resolved. The overall result was that the midpoint potential of the 
a602 state was independent of azide whereas the midpoint potential of the o→a605, o→a3 and a→aa3 
couples rapidly decreased with azide concentration. These changes on binding of azide suggest that 
the resulting blue shift is not a direct effect of the azide on heme a but rather it is stabilizing the a602 
form of heme a that is already present in the unligated enzyme. The a602 form was also found to be 
stabilized in the living cells on addition of azide further confirming that we are able to make precise 
measurements of CytOx in this system. The effect of azide binding to the high affinity site on the 
midpoint potential of the o→a605 and o→a3 couples is similar to the removal of the interacting 
proton, suggesting that azide possibly stabilizes the structure with this site unprotonated. 
The dependence of Kd on reduction state is consistent with the low affinity site being at the BNC as 
the negative charge would lower the midpoint potential of heme a3 and, to lesser extent, heme a as 
it is further away. The same argument could be made for the high affinity site: it also involves 
binding at the BNC rather than at the peripheral site in the crystal structure, although steric 
hindrance would preclude two azides in the BNC. If azide does bind with high affinity to the 
peripheral site then there must be some anti-cooperative mechanism to eject this azide from this site 
when cyanide binds at the BNC [49]. A recent femtosecond x-ray crystallography study has shown 
that, on disassociation of CO from heme a3, there is a distortion of the porphyrin ring and 
movement of Val380, which contacts with the face of the C pyrrole ring. This movement leads to 
the partial unwinding of helix X at residues 380-384 [51] which runs between heme a and a3 and 
contains their axial ligands His378 and His376, respectively. Helix X also contains Ser382 which 
H-bonds to the hydroxyl at the top of the farnesyl side chain of heme a in the oxidized enzyme but 
not the reduced enzyme [44], and Tyr379 that H-bonds to the azide bound at the peripheral site 
[49]. This conformational change could be the anti-cooperative coupling between the binding of 
cyanide to heme a3 and binding of azide at the peripheral site, as the crystal structure of the former 
is in the wound conformation and the latter in the unwound conformation [51]. 
5. Conclusion 
This work confirms and extends our previous work in mouse cells. We show conclusively that there 
are two spectral forms of heme a: the classic form with a peak at 605nm and a second form with a 
peak at 602nm. Our titrations in the azide-ligated enzyme were, for the first time, able to resolve the 
two azide binding sites and suggest that binding at the peripheral site of the crystal structure is also 
able to stabilize the 602nm form of heme a. We have extended the standard 4-state redox 
anticooperativity model to include two states in which only heme a is reduced but has either the 602 
or 605nm form, and shown that the pH-dependence of the midpoint potentials of these two states is 
very different. This 5-state model reproduces the anticooperativity between the hemes of a standard 
4-state model and can, for the first time, rigorously account for the spectral shifts seen during redox 
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titrations. Using these spectral components to analyze the spectra from CytOx after CO photolysis 
in the mixed valence enzyme [12] or after photo injection of an electron in the CuA site [8] would 
likely provide information as to the conditions that generate this blue shift. Finally, this work also 
confirms that we are able to successfully perform redox titrations in living cells and accurately 
determine the heme midpoint potentials. The advantage of working in the living cell is that the 
CytOx is in its authentic environment, is pumping protons against the proton motive force (which 
can be quantified [52]), and is subject to post translational changes [53]. 
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Figure Legends 
Figure 1. Changes in the α-band attenuation spectrum of CytOx on reduction from the oxidized 
state at pH 8.0. The Grey vertical line is drawn at 605nm to emphasize the small spectral shift. The 
inset shows the spectrum at a redox potential of 280mV minus the fully oxidized spectrum (red) and 
the fully reduced spectrum minus the spectrum at 280mV (blue). 
Figure 2. Wavelength shift of the α-band of heme a as a function of redox potential at increasing 
pHs (7.0, 7.5, 8.0, 8.5 and 9.0). Blue and red traces indicate the absence of calcium (chelated by 
200μM BAPTA) and presence of calcium (addition of 250μM CaSO4), respectively. Inset: 
wavelength shift when fully reduced. Green bars are the shift on calcium binding to the fully 
reduced enzyme. 
Figure 3. The fraction of the a605 and a602 spectra to the attenuation spectrum of fully reduced 
CytOx as a function of pH. CytOx was reduced with NADH, using PES as a redox mediator, and in 
the presence of 200μM BAPTA to chelate calcium. Data points are from 3 studies and the lines are 
from a disassociation function with a pKa of 9.4. 
Figure 4. Redox titrations of the α-band of CytOx at pH 7.5. The experimental data is shown as 
points, the lines are a fit to a redox model and the spectra for the fitting model are shown in the 
insert. a) Titrations from the α-band using the standard a605 and a3 spectra along with the a602 
spectrum. The data was fit to a 5 state model of redox cooperativity. b) The same spectra data as a) 
but fitted using a linear combination of the a605 and a602 spectra which titrate as n=1 Nernst 
functions (lines). c) Titrations from the Soret-band using the reference spectrum of heme a (a446) 
and a3, and the reference spectrum of heme a blue shifted by 3nm (a443). The lines are from the 
model in a) shown to emphasize the differences between the data obtained from the α- and Soret-
bands. 
Figure 5. Redox titrations of the α-band of CytOx at increasing pH (6.0 to 9.0). The experimental 
data is displayed as points and the lines are a fit to a 15-state (o, a602, a605, a3 and aa3 with 0, 1 or 
2 bound protons) model with the standard energies fitted simultaneously to all the data points. 
Figure 6. pH dependence of a) the standard energies, b) midpoint potentials and c) number of bound 
protons of the 15-state model fitted to the data of fig. 5. The data points in b) are the midpoint 
potentials of a 5 state model fitted individually to the data at each pH. 
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Figure 7. Redox titrations of the α-band of CytOx at increasing concentrations of sodium azide (pH 
8.0). The points are the data and the lines are from a simultaneous fit to a redox model which 
consisted of unligated and singly ligated o, a602, a605, a3 and aa3, and doubly ligated o and a602. 
Figure 8. Effective midpoint potentials in the presence of azide. The solid lines are the predicted 
midpoint potentials from the redox model with both binding sites and the dotted lines are the 
midpoint potentials for only the high affinity site. The triangles are the midpoint potentials of a 5 
state model fitted individually to the data at each pH. The circles are the midpoint potentials from 
the mouse cells. 
Figure 9. Redox titrations of the α-band of CytOx from living RAW 264.7 macrophages in the 
absence and presence of 1mM of sodium azide. 
Tables 
 
State E0 (0H
+
) E0 (1H
+
) E0 (2H
+
) pKa  0→1 pKa 1→2 
O 0 -33.2±7.8 68.8±18.6 7.54±0.13 5.34±0.43 
a602 -317.5±1.1 -344.6±4.3 -297.1±4.7 7.44±0.09 6.23±0.03 
a605 -235.9±16.5 -349.0±4.4 -275.6±4.4 8.84±0.34 5.81±0.11 
a3 -236.4±8.6 -370.3±4.8 -286.1±9.9 9.18±0.07 5.63±0.08 
aa3 -510.2±2.6 -596.0±3.7 -536.1±6.4 8.39±0.10 6.03±0.05 
Table 1 Standard energies for unprotonated, singly protonated and double protonated states, and 
pKas for the model of fig. 4. Values are expressed as mean±SD (n=3 sets of titrations with each set 
having 7 pHs 
 
 
 
 
 
Em +FCCP −Azide +Azide 
o→a602 329.9±4.3 325.4±3.0 333.3±2.4 
o→a605 251.2±19 297.6 ±2.2 <230 
o→a3 292.9±2.9 315.7±7.3 283.0±6.1 
a3→aa3 223.9±7.9 243.9±3.2 243.3±5.9 
Table 2. Midpoint potentials (Em) for a 5 state redox model to redox titrations carried out in RAW 
264.7 mouse macrophages in the presence or absence of 1mM azide. +FCCP reanalysis of the 
FCCP treated data from [21] in the absence of azide. Values are presented as mean±SD (n=6, 4 and 
4, respectively) 
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